Sophia Genetics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$18,323
$17,779
$17,733
$15,853
Gross Profit
12,270
12,208
12,102
10,654
EBITDA
-18,723
-13,926
-12,229
-13,150
EBIT
-21,093
-16,223
-14,516
-15,363
Net Income
-22,414
-17,385
-15,158
-18,438
Net Change In Cash
18,323
17,779
17,733
15,853
Free Cash Flow
-9,446
-12,241
-12,541
-10,703
Cash
94,822
68,528
80,226
95,787
Basic Shares
67,321
66,844
66,665
66,383

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$65,173
$62,371
$47,560
$40,450
Gross Profit
43,937
42,913
31,254
25,221
EBITDA
-51,487
-70,700
-82,667
-70,837
EBIT
-60,083
-79,036
-88,238
-74,446
Net Income
-62,493
-78,981
-87,449
-73,675
Net Change In Cash
65,173
62,371
47,560
40,450
Free Cash Flow
-50,998
-57,801
-80,474
-64,610
Cash
80,226
123,251
161,305
192,962
Basic Shares
66,062
64,750
64,099
63,857

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.24
2025-03-31
-$0.26
2024-12-31
-$0.11